Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.

Autor: Turla, Antonella1 (AUTHOR) a.turla@unibs.it, Laganà, Marta1 (AUTHOR) m.lagana001@unibs.it, Abate, Andrea2 (AUTHOR) andrea.abate@unibs.it, Cremaschi, Valentina1 (AUTHOR) manuel.zamparini@unibs.it, Zamparini, Manuel1 (AUTHOR) m.chitto@studenti.unibs.it, Chittò, Matteo1 (AUTHOR) francesca.consoli@libero.it, Consoli, Francesca1 (AUTHOR) a.alberti015@unibs.it, Alberti, Andrea1 (AUTHOR) salvatore.grisanti@unibs.it, Ambrosini, Roberta3 (AUTHOR) robertambrosini@gmail.com, Tamburello, Mariangela2 (AUTHOR) mariangela.tamburello@unibs.it, Grisanti, Salvatore1 (AUTHOR) d.cosentini@unibs.it, Tiberio, Guido Alberto Massimo4 (AUTHOR) guido.tiberio@unibs.it, Sigala, Sandra2 (AUTHOR) sandra.sigala@unibs.it, Cosentini, Deborah1 (AUTHOR) alfredo.berruti@unibs.it, Berruti, Alfredo1 (AUTHOR)
Zdroj: Cancers. Sep2023, Vol. 15 Issue 18, p4491. 11p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje